Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis.

Kristopher P Croome Amit K MathurShennen MaoBashar AqelJacob PiattPeter SenadaJulie K HeimbachAdyr MossCharles B RosenC Burcin Taner

Published in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2020)

DCD donors with mild macrosteatosis < 30% can be utilized with no increase in perioperative complications and similar patient and graft survival compared to DCD donors with no steatosis. When utilizing DCD donors with moderate macrosteatosis higher rates of PRS, PNF, postreperfusion cardiac arrest, EAD, and AKI should be anticipated.

Keyphrases

cardiac arrest
cardiac surgery
kidney transplantation
patients undergoing
acute kidney injury
cardiopulmonary resuscitation
insulin resistance
high fat diet
risk factors
high intensity
clinical trial
adipose tissue
high fat diet induced
double blind